Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

dc.contributor.authorBilici, A.
dc.contributor.authorOlmez, O. F.
dc.contributor.authorGursoy, P.
dc.contributor.authorCubukcu, E.
dc.contributor.authorYildiz, O.
dc.contributor.authorSakin, A.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorCil, I.
dc.contributor.authorCakar, B.
dc.contributor.authorMenekse, S.
dc.contributor.authorDemir, T.
dc.contributor.authorAcikgoz, O.
dc.contributor.authorHamdard, J.
dc.date.accessioned2023-02-21T12:40:07Z
dc.date.available2023-02-21T12:40:07Z
dc.date.issued2019-01-01
dc.description.issue10
dc.description.issueS
dc.description.pagesOCT
dc.description.volume14
dc.identifier.doi10.1016/j.jtho.2019.08.1407
dc.identifier.urihttps://hdl.handle.net/11443/2581
dc.identifier.urihttp://dx.doi.org/10.1016/j.jtho.2019.08.1407
dc.identifier.wosWOS:000492162203322
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.titleSystemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with.pdf
Size:
348.99 KB
Format:
Adobe Portable Document Format

Collections